The objective of this study is to analyze a species of plant that is found across the southern and central parts of tropical India and is known to have a variety of therapeutic uses, as well as inflammation, diabetes, infection, and other ailments. Manilkara hexandra (Roxb.) Dubard (Khirini or Rayan) is a species found in southern and central tropical India, Madhya Pradesh, and Maharashtra. It is a long-standing used remedial plant for inflammation, diabetes, infections, neurological disorders, liver, and gastrointestinal disorders. This plant is known to have bioactive phytoconstituents, such as flavonoids, tannins, triterpenoids, alkaloids, glycosides, and several phenolic compounds, which are known for their antioxidants, anti-inflammatory, antimicrobial, hepatoprotective, anti-diabetic, and other properties. Common pharmacological activities of this plant include anxiolytic. Hydroalcoholic extracts of the leaves and bark have provided evidence of such activities. Leaf extract gave a significant reaction, for example, in anti- arthritic activity in rats at 250mg, and a significant increase in glucose metabolism at 300 and 600 mg/kg. Locals use the seeds as a tonic and aphrodisiac. Extracts of the plant have altered the level of pro-inflammatory cytokines as well as inhibited the formation of β-hematin, involved in the anti-plasmodial activity. Nonetheless, positive findings in different in vivo and in vitro studied activities were noted, and thorough toxicological studies and clinical trials were not done. For M. hexandra, though attention must still be given to mechanisms, safety, and standardization of formulations, the plant is a promising candidate in the management of several chronic metabolic, inflammatory, infectious, and neurological disorders, as the plant should be recognized as a confirmed phytopharmaceutical.